sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
United Kingdom In Vitro Fertilization Market, By Product ; By Cycle Type ; By End User, Trend Analysis, Competitive Landscape & Forecast, 2019-2029

United Kingdom In Vitro Fertilization Market, By Product ; By...

Home / Categories / Healthcare
United Kingdom In Vitro Fertilization Market, By Product ; By Cycle Type ; By End User, Trend Analysis, Competitive Landscape & Forecast, 2019-2029
United Kingdom In Vitro Fertilization...
Report Code
RO1/128/1125

Publish Date
19/Jul/2023

Pages
200
PRICE
$ 4900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5400/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8700/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. United Kingdom In Vitro Fertilization (IVF) Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising number of fertility clinics
3.2.1.2. Declining fertility rate
3.2.1.3. Growing rate of obesity and increased consumption of alcohol
3.2.2. Restraints
3.2.2.1. High Cost associated with IVF procedures
3.2.2.2. Restrictive regulations and ethical concerns
3.2.3. Opportunities
3.2.3.1. Rising medical tourism
3.2.3.2. Increasing usage of fertility options by single parents and same-sex couples
3.2.4. Challenges
3.2.4.1. Reducing efficacy of infertility treatment among patients with advancing age
3.3. Technological Advancement/Recent Development
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. United Kingdom In Vitro Fertilization (IVF) Market Overview
4.1. Market Size & Forecast, 2019-2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Equipment
4.2.1.1.1. Imaging Systems
4.2.1.1.2. Incubators
4.2.1.1.3. Cryosystems
4.2.1.1.4. IVF Cabinet
4.2.1.1.5. Ovum Aspiration Pump
4.2.1.1.6. Sperm Separation Systems
4.2.1.1.7. Micromanipulator Systems
4.2.1.1.8. Others
4.2.1.2. Reagents and Media
4.2.1.2.1. Cryopreservation Media
4.2.1.2.2. Embryo Culture Media
4.2.1.2.3. Ovum Processing Media
4.2.1.2.4. Sperm Processing Media
4.2.1.3. Accessories
4.2.2. By Cycle Type
4.2.2.1. Fresh Donor
4.2.2.2. Frozen Donor
4.2.2.3. Fresh Non-donor
4.2.2.4. Frozen Non-donor
4.2.3. By Type
4.2.3.1. Conventional IVF
4.2.3.2. IVF with ICSI
4.2.3.3. IVF with Donor Eggs
4.2.3.4. Others
4.2.4. By End User
4.2.4.1. Fertility Clinics
4.2.4.2. Hospitals
4.2.4.3. Surgical Centers
4.2.4.4. Clinical Research Institutes
5. Competitive Landscape
5.1. List of Key Players and Their Range
5.2. United Kingdom In Vitro Fertilization (IVF) Company Market Share Analysis, 2022
5.3. Competitive Benchmarking, By Operating Parameters
5.4. Key Strategic Development (Merger, Acquisition, Partnership)
6. Impact of Covid-19 on United Kingdom In Vitro Fertilization (IVF) Market Industry
7. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook, SWOT Analysis)
7.1. Bourn Hall Clinic
7.2. CARE Fertility Group
7.3. HCA International Limited
7.4. TFP Fertility Group
7.5. CREATE Fertility
7.6. The Centre for Reproductive & Genetic Health
7.7. London Women's Clinic
7.8. Manchester Fertility
7.9. Chelsea and Westminster Hospital
7.10. The Bridge Centre
7.11. Other prominent players
8. Key Strategic Recommendations
9. Research Methodology
9.1. Qualitative Research
9.1.1. Primary & Secondary Research
9.2. Quantitative Research
9.3. Market Breakdown & Data Triangulation
9.3.1. Secondary Research
9.3.2. Primary Research
9.4. Breakdown of Primary Research Respondents
9.5. Assumption & Limitation
*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com